David M. Knott Jr’s ADMA Biologics ADMA Stock Holding History

David M. Knott Jr’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60,200	Closed	-$542K	–	86
2026 Q1	$542K	Hold	60,200	–	–	0.32%	45
2025 Q4	$1.1M	Buy	+60,200	New	+$1.01M	0.51%	32
2023 Q2	–	Sell	-78,143	Closed	-$259K	–	148
2023 Q1	$259K	Sell	78,143 -54,158	-41%	-$187K	0.1%	67
2022 Q4	$513K	Sell	132,301 -20,000	-13%	-$61.7K	0.19%	58
2022 Q3	$370K	Hold	152,301	–	–	0.16%	75
2022 Q2	$302K	Hold	152,301	–	–	0.13%	83
2022 Q1	$279K	Hold	152,301	–	–	0.09%	90
2021 Q4	$215K	Buy	+152,301	New	+$200K	0.07%	89

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

David M. Knott Jr's ADMA Position: Q2 2026 in Review

David M. Knott Jr sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 60,200 shares — an estimated $542K sold.

David M. Knott Jr first reported a position in ADMA in Q4 2021 and held it in 8 quarters. The position peaked at $1.1M in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

David M. Knott Jr reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
David M. Knott Jr sold 60,200 ADMA Biologics shares in Q2 2026, an estimated $542K.
David M. Knott Jr first reported a position in ADMA Biologics in Q4 2021 and held it in 8 quarters.
David M. Knott Jr's ADMA Biologics position peaked at $1.1M in Q4 2025.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.